Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
06/04/2003 | EP1315699A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
06/04/2003 | EP1315501A1 Alpha v integrin receptor antagonists |
06/04/2003 | EP1165543B1 PROCESS FOR PREPARING S-(R*,S*)] -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES |
06/04/2003 | EP1121121B1 Methods for inhibiting diabetic complications |
06/04/2003 | EP0966439B1 Certain cyclic thio substituted acylaminoacid amide derivatives |
06/04/2003 | EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase |
06/04/2003 | EP0819120B1 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
06/04/2003 | EP0626848B1 The use of 4-aminopyridine in the treatment of pain and spasticity resulting from spinal cord injury |
06/04/2003 | CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
06/04/2003 | CN1422251A Novel alpha-sulfin-and alpha-sulfonamino acid amide derivatives |
06/04/2003 | CN1422250A Alpha-sulfin-and alpha-sulfonamino acid amide derivatives |
06/04/2003 | CN1422249A Novel alpha-sulfin-and alpha-sulfonamino acid amides |
06/04/2003 | CN1421439A Process for producing insecticide intermediate |
06/04/2003 | CN1421436A Prepn process of 2,3,5,6-tetrachloropyridine |
06/04/2003 | CN1421435A Pyridine chloridizing process of producing mixture of pyridine tetrachloride and pyridine pentachloride |
06/04/2003 | CN1110481C Process for synthesizing 2-chloropyridine from chlorine and pyridine |
06/04/2003 | CN1110480C Process for producing propionic aid derivatives |
06/04/2003 | CN1110467C Process for producing alpha-olefins |
06/03/2003 | USRE38133 Kappa agonist compounds and pharmaceutical formulations thereof |
06/03/2003 | US6573289 Naphthalene derivatives, their production and use |
06/03/2003 | US6573284 Method of treating melanoma |
06/03/2003 | US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
06/03/2003 | US6573264 Heteroaryl alkyl piperazine derivatives |
06/03/2003 | US6573260 Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
06/03/2003 | US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability |
06/03/2003 | US6572665 For use in hair coloring formulations |
06/03/2003 | CA2285914C Process and intermediates for a .beta.3-adrenergic receptor agonist |
06/03/2003 | CA2088934C High contrast distorted helix effect electro-optic devices and tight ferroelectric pitch ferroelectric liquid crystal compositions useful therein |
06/03/2003 | CA2053954C Process for the preparation of nitroguanidine derivatives |
05/30/2003 | WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
05/30/2003 | WO2003043990A1 Pyridine-3-sulfonyl compounds as pesticidal agents |
05/30/2003 | WO2003043958A1 Method for the production of vinyl-arenes, -heteroarenes and 1,3-dienes from aryl-, heteroaryl- or vinyl-carboxylic acid derivatives |
05/30/2003 | WO2003043735A2 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions |
05/30/2003 | WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease |
05/30/2003 | WO2003043578A2 Modulators of rho c activity |
05/30/2003 | WO2002094765A3 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof |
05/30/2003 | CA2467910A1 Modulators of rho c activity |
05/30/2003 | CA2467476A1 Amino diols useful in the treatment of alzheimer's disease |
05/30/2003 | CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
05/30/2003 | CA2465818A1 Pyridine-3-sulfonyl compounds as pesticidal agents |
05/29/2003 | US20030100766 3-substituted pyridine compounds and related synthesis |
05/29/2003 | US20030100760 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles |
05/29/2003 | US20030100753 Process for the production of quinazolines |
05/29/2003 | US20030100608 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
05/29/2003 | US20030100583 Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them |
05/29/2003 | US20030100580 Benzenesulfonamide derivatives; for treatment of cardiovascular disorders |
05/29/2003 | US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
05/29/2003 | US20030100539 Metabotropic glutamate receptors (mGluR); treating fragile X, autism, mental retardation, schizophrenia and Down's Syndrome |
05/29/2003 | US20030100441 Polymerization of olefin |
05/29/2003 | US20030100119 Combinatorial synthesis and screening of supported organometallic compounds and catalysts |
05/28/2003 | EP1314980A2 A system for cell-based screening |
05/28/2003 | EP1314721A1 Novel propenohydroxamic acid derivatives |
05/28/2003 | EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
05/28/2003 | EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
05/28/2003 | EP1313709A1 Pyrazolyl biphenyl carboxamides |
05/28/2003 | EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists |
05/28/2003 | EP1313704A2 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
05/28/2003 | EP1313695A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
05/28/2003 | EP1313477A1 Compounds and methods |
05/28/2003 | EP1206427A4 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
05/28/2003 | EP1027403B1 5-arylindane derivatives and ferroelectric liquid crystal mixture containing same |
05/28/2003 | EP0850222B1 Piperazine derivatives and process for the preparation thereof |
05/28/2003 | EP0788360B1 Boronic ester and acid compounds, synthesis and uses |
05/28/2003 | CN1420872A Caspase inhibitors and use thereof |
05/28/2003 | CN1420111A Naphthalene alizarin derivatives, preparing method and use thereof |
05/28/2003 | CN1109544C Beta-alkoxyacrylates against malaria |
05/27/2003 | US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors |
05/27/2003 | US6570020 Reacting 2-(3,3,3-trifluoropropyl),2-hydroxy,4a-benzyl-7-carboxy-1,2,3,4,4a,9,10,10a -octahydrophenanthrene with 2-methyl-3-(aminomethyl)pyridine to form the corresponding pyridyl-substituted amide at position 7 |
05/27/2003 | US6570017 Preparation of dialkylpyridylboranes |
05/27/2003 | US6569882 Viricides; enzyme inhibitors |
05/27/2003 | US6569878 Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors |
05/27/2003 | US6569835 Hypolipidemics; treating obesity and disorders of lipid metabolism |
05/27/2003 | US6569544 Electroluminescent device |
05/27/2003 | US6569361 Polycondensation or polyaddition of electrochromic monomers are used in devices for variable transparency |
05/22/2003 | WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
05/22/2003 | WO2003042186A1 Dithiocarbamate derivatives and their use as antibacterial agents |
05/22/2003 | WO2003042171A1 Vitamin d derivatives with acyloxy groups at the 24-position of the side chain, a method for producing the same and use thereof in production of medicaments |
05/22/2003 | WO2003042168A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES |
05/22/2003 | WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES |
05/22/2003 | WO2003042166A2 PROCESS FOR PREPARATION OF α-HYDROXYCARBOXYLIC ACID AMIDES |
05/22/2003 | WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists |
05/22/2003 | WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists |
05/22/2003 | WO2003042153A1 Difluoroalkene derivative and pest control agent containing the same |
05/22/2003 | WO2003042147A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents |
05/22/2003 | WO2003041728A1 Novel phenyl-propargylether derivatives |
05/22/2003 | WO2003041707A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
05/22/2003 | WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors |
05/22/2003 | WO2002038628A3 Substituted pyridyl amine ligands, complexes and catalysts therefrom; processes for producing polyolefins therewith |
05/22/2003 | WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
05/22/2003 | US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists |
05/22/2003 | US20030096998 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections |
05/22/2003 | US20030096996 Process for producing organotitanium compound and process for addition reaction |
05/22/2003 | US20030096847 For treatment and/or prevention of disorders in the central nervous system, particularly amnesia, dementia, Alzheimer's dementia |
05/22/2003 | US20030096844 Cannabinoid receptor ligands |
05/22/2003 | US20030096843 Preventives/remedies for kidney diseases |
05/22/2003 | US20030096828 Cyclic amide compound |
05/22/2003 | US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
05/22/2003 | US20030096817 Inhibiting mammalian protein kinases (p38) with (2,6-difluoro-phenyl)-(5-iodo-pyridin-2-yl)amine for treatment of cardiovascular disorders |
05/22/2003 | US20030096802 Pentanoic acid derivatives |
05/22/2003 | US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders |